Home

|

EVMPD

|

Solution

 Pharma eReport Blog

Date: 15th September 2014, by: Nicky
Tags: XEVMPD, EMA

Pharma eReport delivers V5-compliant solution to help MAHs meet December 31st XEVMPD resubmission deadline

Centrality software is fully compliant with EMA V5 schema updates and available now to pharmaceutical Marketing Authorisation Holders

Cambridge, UK, September xx 2014—Pharma eReport, a software and services company that delivers a comprehensive XEVMPD compliance solution for pharmaceutical regulatory professionals, today announces that its Centrality software is fully compliant with the latest XEVMPD schema changes mandated by the European Medicines Agency (EMA).  Centrality offers Marketing Authorisation Holders a straightforward mechanism to import existing product data, update it to the new V5 schema and submit it to the EMA.  The software has been successfully managing the re-submission process for customers since the V5 update came into force on 16th June 2014.  Prospective users can register for a free online demonstration now at http://www.pharmereport.com

On January 31st 2014, the EMA substantially changed the requirements for the product data that pharmaceutical companies must submit to the Eudravigilance Medicinal Product Dictionary, or XEVMPD. All Marketing Authorisation Holders (MAHs) must have updated their product records in accordance with the EMA’s “V5” guidance by December 31st 2014.  The mandatory changes are being made to address a range of issues on the road to the implementation of ISO IDMP (Identification of Medicinal Products) in 2016, including new information required to support the assignment of pharmacovigilance fees, improvements to the quality of submitted data, and modification of controlled vocabularies. 

Pharma eReport’s quality-assured, V5-compliant Centrality software is being used today by major global pharmaceutical companies to manage ongoing XEVMPD compliance. Built directly from the EMA schema to ensure syntactically correct EudraVigilance Product Report Message (EVPRM) messages by construction, Centrality also incorporates built-in business rules, so that the entire process – from data entry through to submission to the EMA gateway – is error-free, continuously cross-checked and seamlessly compliant.

Pharma eReport’s solution offers extensive data import capabilities and transparently interfaces with customers’ existing data systems. With the additional option of a full range of specialist support and consulting services, Pharma eReport enables customers to outsource the entire XEVMPD compliance process.

Commenting on today’s announcement, Marco Rubinstein, CEO of Pharma eReport said: "Our Centrality software is being embraced by major pharmaceutical companies as a technically superior, cost-effective and proven solution to achieving and maintaining XEVMPD compliance.”  He added: “Since our solution has been engineered from the ground up to be both agile and highly robust, we have been able to very quickly adapt our system to the requirements of the V5 update. Whether MAHs are currently using the EV web tool, a different software solution, or even have yet to submit any data to the EMA, we provide a complete, easy-to-implement and fully tested solution for Article 57 compliance that minimises the administrative burden and keeps pace with evolving specifications.”

The Centrality software is offered via a transparent pricing model and with fully flexible deployment options. The Centrality platform is available as a secure, on-demand cloud-based application (Software-as-a-service) accessed via a standard web browser, or it can be installed as a standalone software application.  For customers who wish to have all their data in-house, Centrality can be installed on a company intranet, so that the data is held on-site and authorised users can access it securely via the company system. The Centrality software solution is completely independent – no other software needs to be installed – and offers full support for both Windows and Linux.

To sign-up online for a free demonstration of Pharma eReport’s Centrality software, please visit: http://www.pharmaereport.com

---ends---

Press contacts

Nicky Denovan
Pharma eReport
nicky [at] pharmaereport [dot] com
Phone: +44 (0) 7747 017654

About Pharma eReport (http://www.pharmaereport.com)

Cambridge, UK-based Pharma eReport provides intuitive electronic product data management and reporting software for pharmaceutical regulatory professionals. 

With its Centrality software and supporting specialist XEVMPD services – delivered by a Key Support Services team of qualified chemists – Pharma eReport provides a comprehensive XEVMPD solution, including complete outsourced data collation, organisation and mapping capabilities. The Centrality software is available as an on-demand software-as-a-service (SaaS)/cloud-based solution – accessed via a standard web browser – or it can be installed as a standalone software application at a client site. 

Pharma eReport is co-founded by the management of ELC Group – a leading global services company with recognised expertise in regulatory affairs and Marketing Authorisation management – plus former executives from electronic design automation software company Synopsys, Inc.   Pharma eReport harnesses the unparalleled industry knowledge of its regulatory expert founders and combines this with a world-class software development team to deliver a total solution for XEVMPD compliance and beyond.

Blog Posts

15th September 2014, by: Nicky
Tags: XEVMPD, EMA
Pharma eReport delivers V5-compliant solution to help MAHs meet December 31st XEVMPD resubmission deadline

11th September 2014, by: Nicky
Tags: XEVMPD, EMA
Are you ready for the December 31st XEVMPD re-submission deadline?

3rd September 2012, by: Nicky
Tags: IRISS, ISO IDMP, EMA, DIA
IRISS IDMP Topic Group Leader Andrew Marr to present work of group at DIA Conference

24th June 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA
EMA updates eSubmission Gateway Q&A

12th June 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality
XEVMPD software provider Pharma eReport launches Excel Data Import Service

30th May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
Response requested by 30 May 2012: EMA Options Paper

18th May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
XEVMPD e-Learning Course now online

4th May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
April 2012 EMA controlled vocabulary update

1st May 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
EMA to host IDMP Information Day in London on May 8th

23rd April 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA, EudraVigilance
EudraVigilance XEVMPD e-learning course coming very soon

12th April 2012, by: Nicky
Tags: EVMPD, XEVMPD, ISO IDMP
Report: first meeting of IRISS IDMP Topic Group

21st March 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality, software
EVMPD software provider Pharma eReport announces full general availability of Centrality XEVMPD compliance solution

14th March 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality, software
Seven reasons to invest in an EVPRM system

13th March 2012, by: Nicky
Tags: EVMPD, XEVMPD
New: EVMPD spreadsheet for data entry freely available on our website

6th March 2012, by: Nicky
Tags: EVMPD, XEVMPD, EMA
Updated EVMPD guidance from EMA

21st February 2012, by: Nicky
Tags: EVMPD, XEVMPD, Centrality, Pharma eReport
We've launched!

20th February 2012, by: Nicky
Tags: EVMPD, XEVMPD, report
Call for participation: IRISS Forum topic group on Identification of Medicinal Products (including XEVMPD)

2nd February 2012, by: Lloyd
Tags: EMA
SSI to be optional

2nd February 2012, by: Nicky
Tags: EVMPD, XEVMPD, report
End of year EVMPD report from Marr Consultancy

31st January 2012, by: Nicky
Tags: EVMPD, XEVMPD, Article 57, blog, Pharma eReport
Welcome to our blog!